Global Influenza Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 203708
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Influenza Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Influenza Therapeutics size is estimated to be USD 8182 million in 2026 from USD 6836.6 million in 2020, with a change XX% between 2020 and 2021. The global Influenza Therapeutics market size is expected to grow at a CAGR of 4.6% for the next five years.

Market segmentation

Influenza Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Vaccines

Drugs

Market segment by Application, can be divided into

Hospitals

Clinic

Others

Market segment by players, this report covers

Abbott Laboratories

Astrazeneca PLC

Biocryst Pharmaceuticals, Inc.

Chiron Corporation

CSL Limited

Daiichi Sankyo Co., Ltd.

Glaxosmithkline PLC

Mitsubishi Tanabe Pharma Corporation

Nanotherapeutics Inc.

Protein Sciences Corporation

Roche Holding AG

Sanofi SA

Shionogi & Co., Ltd.

Sinovac Biotech Ltd.

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Influenza Therapeutics

1.2 Classification of Influenza Therapeutics by Type

1.2.1 Overview: Global Influenza Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Influenza Therapeutics Revenue Market Share by Type in 2020

1.2.3 Vaccines

1.2.4 Drugs

1.3 Global Influenza Therapeutics Market by Application

1.3.1 Overview: Global Influenza Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Global Influenza Therapeutics Market Size & Forecast

1.5 Global Influenza Therapeutics Market Size and Forecast by Region

1.5.1 Global Influenza Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Influenza Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Influenza Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Influenza Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Influenza Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Influenza Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Influenza Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Influenza Therapeutics Market Drivers

1.6.2 Influenza Therapeutics Market Restraints

1.6.3 Influenza Therapeutics Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Influenza Therapeutics Product and Solutions

2.1.4 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Astrazeneca PLC

2.2.1 Astrazeneca PLC Details

2.2.2 Astrazeneca PLC Major Business

2.2.3 Astrazeneca PLC Influenza Therapeutics Product and Solutions

2.2.4 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Astrazeneca PLC Recent Developments and Future Plans

2.3 Biocryst Pharmaceuticals, Inc.

2.3.1 Biocryst Pharmaceuticals, Inc. Details

2.3.2 Biocryst Pharmaceuticals, Inc. Major Business

2.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions

2.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans

2.4 Chiron Corporation

2.4.1 Chiron Corporation Details

2.4.2 Chiron Corporation Major Business

2.4.3 Chiron Corporation Influenza Therapeutics Product and Solutions

2.4.4 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Chiron Corporation Recent Developments and Future Plans

2.5 CSL Limited

2.5.1 CSL Limited Details

2.5.2 CSL Limited Major Business

2.5.3 CSL Limited Influenza Therapeutics Product and Solutions

2.5.4 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 CSL Limited Recent Developments and Future Plans

2.6 Daiichi Sankyo Co., Ltd.

2.6.1 Daiichi Sankyo Co., Ltd. Details

2.6.2 Daiichi Sankyo Co., Ltd. Major Business

2.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions

2.6.4 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans

2.7 Glaxosmithkline PLC

2.7.1 Glaxosmithkline PLC Details

2.7.2 Glaxosmithkline PLC Major Business

2.7.3 Glaxosmithkline PLC Influenza Therapeutics Product and Solutions

2.7.4 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Glaxosmithkline PLC Recent Developments and Future Plans

2.8 Mitsubishi Tanabe Pharma Corporation

2.8.1 Mitsubishi Tanabe Pharma Corporation Details

2.8.2 Mitsubishi Tanabe Pharma Corporation Major Business

2.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions

2.8.4 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans

2.9 Nanotherapeutics Inc.

2.9.1 Nanotherapeutics Inc. Details

2.9.2 Nanotherapeutics Inc. Major Business

2.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions

2.9.4 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Nanotherapeutics Inc. Recent Developments and Future Plans

2.10 Protein Sciences Corporation

2.10.1 Protein Sciences Corporation Details

2.10.2 Protein Sciences Corporation Major Business

2.10.3 Protein Sciences Corporation Influenza Therapeutics Product and Solutions

2.10.4 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Protein Sciences Corporation Recent Developments and Future Plans

2.11 Roche Holding AG

2.11.1 Roche Holding AG Details

2.11.2 Roche Holding AG Major Business

2.11.3 Roche Holding AG Influenza Therapeutics Product and Solutions

2.11.4 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Roche Holding AG Recent Developments and Future Plans

2.12 Sanofi SA

2.12.1 Sanofi SA Details

2.12.2 Sanofi SA Major Business

2.12.3 Sanofi SA Influenza Therapeutics Product and Solutions

2.12.4 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Sanofi SA Recent Developments and Future Plans

2.13 Shionogi & Co., Ltd.

2.13.1 Shionogi & Co., Ltd. Details

2.13.2 Shionogi & Co., Ltd. Major Business

2.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions

2.13.4 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Shionogi & Co., Ltd. Recent Developments and Future Plans

2.14 Sinovac Biotech Ltd.

2.14.1 Sinovac Biotech Ltd. Details

2.14.2 Sinovac Biotech Ltd. Major Business

2.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions

2.14.4 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Sinovac Biotech Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Influenza Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Influenza Therapeutics Players Market Share

3.2.2 Top 10 Influenza Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Influenza Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Influenza Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Influenza Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Influenza Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Influenza Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Influenza Therapeutics Revenue by Type (2016-2026)

6.2 North America Influenza Therapeutics Revenue by Application (2016-2026)

6.3 North America Influenza Therapeutics Market Size by Country

6.3.1 North America Influenza Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Influenza Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Influenza Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Influenza Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Influenza Therapeutics Revenue by Type (2016-2026)

7.2 Europe Influenza Therapeutics Revenue by Application (2016-2026)

7.3 Europe Influenza Therapeutics Market Size by Country

7.3.1 Europe Influenza Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Influenza Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Influenza Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Influenza Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Influenza Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Influenza Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Influenza Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Influenza Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Influenza Therapeutics Market Size by Region

8.3.1 Asia-Pacific Influenza Therapeutics Revenue by Region (2016-2026)

8.3.2 China Influenza Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Influenza Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Influenza Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Influenza Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Influenza Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Influenza Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Influenza Therapeutics Revenue by Type (2016-2026)

9.2 South America Influenza Therapeutics Revenue by Application (2016-2026)

9.3 South America Influenza Therapeutics Market Size by Country

9.3.1 South America Influenza Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Influenza Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Influenza Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Influenza Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Influenza Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Influenza Therapeutics Market Size by Country

10.3.1 Middle East & Africa Influenza Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Influenza Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Influenza Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Influenza Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Influenza Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Influenza Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Influenza Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Influenza Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Influenza Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Influenza Therapeutics Product and Solutions

Table 9. Abbott Laboratories Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Astrazeneca PLC Corporate Information, Head Office, and Major Competitors

Table 11. Astrazeneca PLC Major Business

Table 12. Astrazeneca PLC Influenza Therapeutics Product and Solutions

Table 13. Astrazeneca PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Biocryst Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Biocryst Pharmaceuticals, Inc. Major Business

Table 16. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions

Table 17. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Chiron Corporation Corporate Information, Head Office, and Major Competitors

Table 19. Chiron Corporation Major Business

Table 20. Chiron Corporation Influenza Therapeutics Product and Solutions

Table 21. Chiron Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. CSL Limited Corporate Information, Head Office, and Major Competitors

Table 23. CSL Limited Major Business

Table 24. CSL Limited Influenza Therapeutics Product and Solutions

Table 25. CSL Limited Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Daiichi Sankyo Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 27. Daiichi Sankyo Co., Ltd. Major Business

Table 28. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions

Table 29. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Glaxosmithkline PLC Corporate Information, Head Office, and Major Competitors

Table 31. Glaxosmithkline PLC Major Business

Table 32. Glaxosmithkline PLC Influenza Therapeutics Product and Solutions

Table 33. Glaxosmithkline PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Mitsubishi Tanabe Pharma Corporation Corporate Information, Head Office, and Major Competitors

Table 35. Mitsubishi Tanabe Pharma Corporation Major Business

Table 36. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions

Table 37. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Nanotherapeutics Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Nanotherapeutics Inc. Major Business

Table 40. Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions

Table 41. Nanotherapeutics Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Protein Sciences Corporation Corporate Information, Head Office, and Major Competitors

Table 43. Protein Sciences Corporation Major Business

Table 44. Protein Sciences Corporation Influenza Therapeutics Product and Solutions

Table 45. Protein Sciences Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Roche Holding AG Corporate Information, Head Office, and Major Competitors

Table 47. Roche Holding AG Major Business

Table 48. Roche Holding AG Influenza Therapeutics Product and Solutions

Table 49. Roche Holding AG Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Sanofi SA Corporate Information, Head Office, and Major Competitors

Table 51. Sanofi SA Major Business

Table 52. Sanofi SA Influenza Therapeutics Product and Solutions

Table 53. Sanofi SA Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Shionogi & Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 55. Shionogi & Co., Ltd. Major Business

Table 56. Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions

Table 57. Shionogi & Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Sinovac Biotech Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. Sinovac Biotech Ltd. Major Business

Table 60. Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions

Table 61. Sinovac Biotech Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Influenza Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 63. Global Influenza Therapeutics Revenue Share by Players (2019-2021)

Table 64. Breakdown of Influenza Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Influenza Therapeutics Players Head Office, Products and Services Provided

Table 66. Influenza Therapeutics Mergers & Acquisitions in the Past Five Years

Table 67. Influenza Therapeutics New Entrants and Expansion Plans

Table 68. Global Influenza Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 69. Global Influenza Therapeutics Revenue Share by Type (2016-2021)

Table 70. Global Influenza Therapeutics Revenue Forecast by Type (2021-2026)

Table 71. Global Influenza Therapeutics Revenue by Application (2016-2021)

Table 72. Global Influenza Therapeutics Revenue Forecast by Application (2021-2026)

Table 73. North America Influenza Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Influenza Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Influenza Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Influenza Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Influenza Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Influenza Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Influenza Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Influenza Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Influenza Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Influenza Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Influenza Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Influenza Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Influenza Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Influenza Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Influenza Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Influenza Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Influenza Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Influenza Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Influenza Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Influenza Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Influenza Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Influenza Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Influenza Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Influenza Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Influenza Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Influenza Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Influenza Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Influenza Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Influenza Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Influenza Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Influenza Therapeutics Picture

Figure 2. Global Influenza Therapeutics Revenue Market Share by Type in 2020

Figure 3. Vaccines

Figure 4. Drugs

Figure 5. Influenza Therapeutics Revenue Market Share by Application in 2020

Figure 6. Hospitals Picture

Figure 7. Clinic Picture

Figure 8. Others Picture

Figure 9. Global Influenza Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Influenza Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Influenza Therapeutics Revenue Market Share by Region (2016-2026)

Figure 12. Global Influenza Therapeutics Revenue Market Share by Region in 2020

Figure 13. North America Influenza Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Influenza Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Influenza Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Influenza Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Influenza Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Influenza Therapeutics Market Drivers

Figure 19. Influenza Therapeutics Market Restraints

Figure 20. Influenza Therapeutics Market Trends

Figure 21. Abbott Laboratories Recent Developments and Future Plans

Figure 22. Astrazeneca PLC Recent Developments and Future Plans

Figure 23. Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 24. Chiron Corporation Recent Developments and Future Plans

Figure 25. CSL Limited Recent Developments and Future Plans

Figure 26. Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans

Figure 27. Glaxosmithkline PLC Recent Developments and Future Plans

Figure 28. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans

Figure 29. Nanotherapeutics Inc. Recent Developments and Future Plans

Figure 30. Protein Sciences Corporation Recent Developments and Future Plans

Figure 31. Roche Holding AG Recent Developments and Future Plans

Figure 32. Sanofi SA Recent Developments and Future Plans

Figure 33. Shionogi & Co., Ltd. Recent Developments and Future Plans

Figure 34. Sinovac Biotech Ltd. Recent Developments and Future Plans

Figure 35. Global Influenza Therapeutics Revenue Share by Players in 2020

Figure 36. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 37. Global Top 3 Players Influenza Therapeutics Revenue Market Share in 2020

Figure 38. Global Top 10 Players Influenza Therapeutics Revenue Market Share in 2020

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 40. Global Influenza Therapeutics Revenue Share by Type in 2020

Figure 41. Global Influenza Therapeutics Market Share Forecast by Type (2021-2026)

Figure 42. Global Influenza Therapeutics Revenue Share by Application in 2020

Figure 43. Global Influenza Therapeutics Market Share Forecast by Application (2021-2026)

Figure 44. North America Influenza Therapeutics Sales Market Share by Type (2016-2026)

Figure 45. North America Influenza Therapeutics Sales Market Share by Application (2016-2026)

Figure 46. North America Influenza Therapeutics Revenue Market Share by Country (2016-2026)

Figure 47. United States Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Canada Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Mexico Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Europe Influenza Therapeutics Sales Market Share by Type (2016-2026)

Figure 51. Europe Influenza Therapeutics Sales Market Share by Application (2016-2026)

Figure 52. Europe Influenza Therapeutics Revenue Market Share by Country (2016-2026)

Figure 53. Germany Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. France Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. United Kingdom Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Russia Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Italy Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Asia-Pacific Influenza Therapeutics Sales Market Share by Type (2016-2026)

Figure 59. Asia-Pacific Influenza Therapeutics Sales Market Share by Application (2016-2026)

Figure 60. Asia-Pacific Influenza Therapeutics Revenue Market Share by Region (2016-2026)

Figure 61. China Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Japan Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South Korea Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. India Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Southeast Asia Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Australia Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South America Influenza Therapeutics Sales Market Share by Type (2016-2026)

Figure 68. South America Influenza Therapeutics Sales Market Share by Application (2016-2026)

Figure 69. South America Influenza Therapeutics Revenue Market Share by Country (2016-2026)

Figure 70. Brazil Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Argentina Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Middle East and Africa Influenza Therapeutics Sales Market Share by Type (2016-2026)

Figure 73. Middle East and Africa Influenza Therapeutics Sales Market Share by Application (2016-2026)

Figure 74. Middle East and Africa Influenza Therapeutics Revenue Market Share by Country (2016-2026)

Figure 75. Turkey Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. UAE Influenza Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz